 |
|
|
| |
Characterization of Host, Viral, and Treatment-Related Factors Associated With Antiviral Efficacy of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate
|
| |
| |
Reported by Jules Levin
APASL 2017 Feb 15-19 Shanghai, China
EJ Gane1, M Saito2, S-H Bae3, P Andreone4, JF Flaherty5, K Kim5, A Gaggar5, GM Subramanian5, F Caruntu6, F Wong7, X Ma8, P Marcellin9
1New Zealand Liver Transplant Unit, Auckland Clinical Studies, Auckland, New Zealand; 2Division of Hepatobillary, and Pancreatic Disease, Department of Internal Medicine , Hyogo College of Medicine, Hyogo, Japan; 3Gastroenterology, Seoul Saint Mary Hospital, Seoul, Korea (the Republic of); 4Scienze Mediche e Chirurgiche, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 5Gilead Sciences, Foster City CA, United States; 6Infectious Diseases, National Institute for Infectious Diseases Matei Bals, Bucharest, Romania; 7University Health Network, Toronto, ON, Canada; 8Xiaoli Ma, PC, Bryn Mawr, PA, United States; 9Service d'Hepatologie, Hopital Beaujon, University of Paris, Clichy, France
|
| |
|
|
|
|
|
